Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26 19:34 | 8/10/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Beckerle Mary C | CA | D | 1 | S | -527 | 53.66 | 0 | -10 | 16 | D | ||||||||||||||||
6/3/26 18:52 | 6/1/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | 1 | S | -198 | 50.55 | 0 | -4 | 284 | D | ||||||||||||||||
6/3/26 18:51 | 6/1/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Eckhardt Sue Gail | CA | D | 1 | S | -492 | 50.14 | 0 | -10 | 16 | D | ||||||||||||||||
5/28/26 18:25 | 5/26/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | EVP,Rese | 1 | S | -2,188 | 50.35 | 0 | -43 | 601 | D | |||||||||||||||
5/22/26 17:01 | 5/20/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Haley Patrick J. | CA | O | EVP,Comm | 1 | S | -1,599 | 49.81 | 0 | -32 | 358 | D | |||||||||||||||
5/19/26 18:58 | 5/18/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Senner Christopher J. | CA | O | EVP,CFO | 1 | S | -1,745 | 50.00 | 0 | -35 | 955 | D | |||||||||||||||
5/19/26 18:58 | 5/18/26 | EXEL | Health | BioPrd | Biological Products, (No Diag | Hefti Brenda | CA | O | SVP,GC | 1 | S | -333 | 50.21 | 0 | -7 | 112 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |